Published in Cancer Weekly, April 24th, 2006
"The HOXB13 and IL17BR gene profile was previously discovered as a potential marker of relapse in hormone-receptor positive breast cancer treated with tamoxifen," says Matthew Goetz, MD, who co-led the project with James Ingle, MD and Fergus Couch, PhD "Our new study shows that the marker is only useful for identifying women with a higher risk in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.